Barnett & Company’s Avanos Medical AVNS Stock Holding History

Barnett & Company’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$35K	–	109
2021 Q4	$35K	Hold	1,000	–	–	0.02%	151
2021 Q3	$31K	Hold	1,000	–	–	0.02%	142
2021 Q2	$36K	Hold	1,000	–	–	0.02%	161
2021 Q1	$44K	Hold	1,000	–	–	0.02%	168
2020 Q4	$45K	Hold	1,000	–	–	0.03%	166
2020 Q3	$33K	Hold	1,000	–	–	0.02%	172
2020 Q2	$29K	Hold	1,000	–	–	0.02%	163
2020 Q1	$27K	Hold	1,000	–	–	0.03%	164
2019 Q4	$34K	Hold	1,000	–	–	0.02%	196
2019 Q3	$37K	Hold	1,000	–	–	0.02%	187
2019 Q2	$44K	Hold	1,000	–	–	0.02%	173
2019 Q1	$43K	Hold	1,000	–	–	0.02%	183
2018 Q4	$45K	Hold	1,000	–	–	0.03%	184
2018 Q3	$69K	Hold	1,000	–	–	0.03%	167
2018 Q2	$57K	Hold	1,000	–	–	0.03%	166
2018 Q1	$46K	Hold	1,000	–	–	0.02%	187
2017 Q4	$46K	Buy	+1,000	New	+$46K	0.02%	191
2017 Q3	–	Sell	-170	Closed	-$7K	–	320
2017 Q2	$7K	Sell	170 -167	-50%	-$6.31K	﹤0.01%	317
2017 Q1	$13K	Sell	337 -50	-13%	-$1.95K	0.01%	271
2016 Q4	$14K	Sell	387 -145	-27%	-$5.18K	0.01%	290
2016 Q3	$18K	Sell	532 -25	-4%	-$876	0.01%	286
2016 Q2	$18K	Hold	557	–	–	0.01%	278
2016 Q1	$16K	Buy	+557	New	+$14.8K	0.01%	294

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barnett & Company's AVNS Position: Q1 2022 in Review

Barnett & Company sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 1,000 shares — an estimated $35K sold.

Barnett & Company first reported a position in AVNS in Q1 2016 and held it in 23 quarters. The position peaked at $69K in Q3 2018. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

Barnett & Company reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
Barnett & Company sold 1,000 Avanos Medical shares in Q1 2022, an estimated $35K.
Barnett & Company first reported a position in Avanos Medical in Q1 2016 and held it in 23 quarters.
Barnett & Company's Avanos Medical position peaked at $69K in Q3 2018.
299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.